CDC to Distribute $40 Million in Recovery Act Funding to Help States Fight Healthcare-Associated Infections
Money marks first time Congress appropriates HAI prevention funds specifically to states
The Centers for Disease Control and Prevention today announced plans to distribute $40 million to state health departments to help prevent healthcare-associated infections (HAIs). Funded by the American Recovery and Reinvestment Act, the money will be distributed through cooperative agreements to 49 states, Washington, D.C., and Puerto Rico to maximize prevention efforts such as:
Creating or expanding state and local efforts to implement recommendations in the U.S. Department of Health and Human Services HAI Action Plan
Increasing health care facilities' and health departments' use of CDC’s National Healthcare Safety Network, a surveillance system that allows HAI data to be tracked, analyzed and compared for prevention efforts
Hiring and training public health staff to promote and lead HAI prevention initiatives
Complementing HAI investments from other HHS agencies
"Americans expect to get better when they go to the hospital, not worse" said HHS Secretary Kathleen Sebelius. "Unfortunately, every year, thousands of Americans die from illness they contract after they enter the hospital. Thanks to Chairman David Obey’s leadership, the Recovery Act includes critical resources that will help fight these infections and keep patients safe."
Efforts will focus on HHS priority targets such as bloodstream infections, surgical site infections and catheter-associated urinary tract infections, and will address pathogens such as methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile (C. diff). The investment represents the first time Congress has appropriated HAI prevention funds specifically to states.
"We expect these programs to strengthen tracking and prevention of healthcare-associated infections, enhance facility accountability, provide data for informed policy, and ultimately save lives," said CDC Director Thomas R. Frieden, M.D., M.P.H. "Funding critical prevention efforts at state and local levels represents a significant investment toward elimination of HAIs and improved patient safety."
CDC estimates that every year, Americans contract 1.7 million infections while being treated in hospitals. These infections are associated with approximately 99,000 deaths annually. In addition to the significant toll on patients’ lives, HAIs represent an estimated $30 billion in added healthcare costs.
HHS has addressed HAIs by coordinating efforts across the Department and creating the HHS action plan which includes five-year national prevention targets to reduce and prevent much of the significant burden to our nation. One of the goals of the HHS Action Plan is to collaborate effectively with public and private sector partners to accomplish the large-scale prevention of HAIs. For instance, CDC is collaborating with several states that have demonstrated that implementing CDC's HAI prevention guidelines and using NHSN to monitor progress can achieve major decreases in HAIs. Prevention success can be characterized in a number of ways. Some states have shown quick reductions after implementing prevention efforts, and others have sustained low infection rates over an extended period of time. For example, in the first six months of 2009, compared to 2008, hospitals in Tennessee achieved a 30 percent reduction of bloodstream infections associated with central lines (a catheter, or tube, that is inserted into a major vein or artery, and that ends up close to or in the heart). In another instance, intensive care units in a New York state hospital group achieved a 70 percent reduction of central line-associated bloodstream infections and sustained these rates for a three-year period.
"Many states and localities have lacked the resources and personnel needed to appropriately address the HAI burden," said Marion Kainer, M.D., M.P.H., director of the Tennessee Department of Health Hospital Infection and Antimicrobial Resistance Program, and HAI prevention lead for the Council of State and Territorial Epidemiologists. "This investment will provide a unique opportunity to make prevention of HAIs a national accomplishment."
Background on HAI Investments in the Recovery Act
The American Recovery and Reinvestment Act of 2009, Public Law 111-5 (ARRA) was signed into law on February 17, 2009. Within the Recovery Act, $50 million was appropriated to support states in the prevention and reduction of healthcare associated infections (HAI). The Centers for Medicare & Medicaid Services (CMS) will use $10 million to improve the process and frequency of inspections for ambulatory surgical centers, while CDC will allocate $40 million to states to create or expand state-based HAI prevention collaboration efforts, enhance state abilities to monitor and track HAIs, and build within health departments a workforce trained in HAI prevention. For more information on the Recovery Act: www.recovery.gov. For more information about CDC’s HAI Recovery Act funding: www.cdc.gov/hai/recoveryact.
###
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
and connect with fellow professionals
At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.
0 Comments
Please log in to post a comment.